GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » EV-to-FCF

Assertio Holdings (FRA:DPOA) EV-to-FCF : 0.74 (As of Jun. 08, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Assertio Holdings's Enterprise Value is €23.5 Mil. Assertio Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €31.7 Mil. Therefore, Assertio Holdings's EV-to-FCF for today is 0.74.

The historical rank and industry rank for Assertio Holdings's EV-to-FCF or its related term are showing as below:

FRA:DPOA' s EV-to-FCF Range Over the Past 10 Years
Min: -337.04   Med: 4.41   Max: 274.37
Current: 1.53

During the past 13 years, the highest EV-to-FCF of Assertio Holdings was 274.37. The lowest was -337.04. And the median was 4.41.

FRA:DPOA's EV-to-FCF is ranked better than
95.9% of 536 companies
in the Drug Manufacturers industry
Industry Median: 23 vs FRA:DPOA: 1.53

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Assertio Holdings's stock price is €0.73. Assertio Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.000. Therefore, Assertio Holdings's PE Ratio for today is N/A.


Assertio Holdings EV-to-FCF Historical Data

The historical data trend for Assertio Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assertio Holdings EV-to-FCF Chart

Assertio Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.61 -1.58 24.50 2.68 1.38

Assertio Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.39 3.51 2.88 1.38 1.46

Competitive Comparison of Assertio Holdings's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Assertio Holdings's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Assertio Holdings's EV-to-FCF falls into.



Assertio Holdings EV-to-FCF Calculation

Assertio Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=23.547/31.726
=0.74

Assertio Holdings's current Enterprise Value is €23.5 Mil.
Assertio Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €31.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Assertio Holdings  (FRA:DPOA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Assertio Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.73/0.000
=N/A

Assertio Holdings's share price for today is €0.73.
Assertio Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Assertio Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Assertio Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Assertio Holdings (FRA:DPOA) Business Description

Traded in Other Exchanges
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Assertio Holdings (FRA:DPOA) Headlines

No Headlines